Literature DB >> 6165800

A comparative study of strains of Ebola virus isolated from southern Sudan and northern Zaire in 1976.

E T Bowen, G S Platt, G Lloyd, R T Raymond, D I Simpson.   

Abstract

During the 1976 Ebola virus outbreak in Sudan, the investigations team gained the impression that fewer haemorrhagic manifestations and few fatalities occurred during the later stages of the epidemic after the virus had undergone several generations in man. This impression was also noted in guinea pigs experimentally infected with Sudanese and Zairean strains of Ebola virus. The virulence of the Sudanese isolates was less intense than isolates emanating from Zaire. Similar findings were seen in monkeys; a Zairean isolated produced fatal infections, whereas monkeys inoculated with a Sudan strain generally recovered. Two monkeys, which had recovered from Sudanese strain infections and had developed high levels of antibody detectable by immunofluorescence, were challenged with the Zairean strain. Both developed viraemias and died. The mechanisms of this "failed protection" are discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6165800     DOI: 10.1002/jmv.1890060205

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  22 in total

Review 1.  Filovirus vaccines.

Authors:  Steven B Bradfute; John M Dye; Sina Bavari
Journal:  Hum Vaccin       Date:  2011-06-01

2.  Managing Ebola from rural to urban slum settings: experiences from Uganda.

Authors:  Sam I Okware; Francis Omaswa; Ambrose Talisuna; Jacinto Amandua; Jackson Amone; Paul Onek; Alex Opio; Joseph Wamala; Julius Lubwama; Lukwago Luswa; Paul Kagwa; Thorkild Tylleskar
Journal:  Afr Health Sci       Date:  2015-03       Impact factor: 0.927

3.  Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine.

Authors:  Kathleen M Daddario-DiCaprio; Thomas W Geisbert; Joan B Geisbert; Ute Ströher; Lisa E Hensley; Allen Grolla; Elizabeth A Fritz; Friederike Feldmann; Heinz Feldmann; Steven M Jones
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates.

Authors:  T G Ksiazek; P E Rollin; P B Jahrling; E Johnson; D W Dalgard; C J Peters
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

5.  Ebola: history, treatment, and lessons from a new emerging pathogen.

Authors:  Kevin S Harrod
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-12-12       Impact factor: 5.464

6.  Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy.

Authors:  Andrea Marzi; Hideki Ebihara; Julie Callison; Allison Groseth; Kinola J Williams; Thomas W Geisbert; Heinz Feldmann
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

7.  Postexposure Protective Efficacy of T-705 (Favipiravir) Against Sudan Virus Infection in Guinea Pigs.

Authors:  Md N Rahim; Zirui Zhang; Shihua He; Wenjun Zhu; Logan Banadyga; David Safronetz; Xiangguo Qiu
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

8.  Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs.

Authors:  Kathleen C Prins; Sebastien Delpeut; Daisy W Leung; Olivier Reynard; Valentina A Volchkova; St Patrick Reid; Parameshwaran Ramanan; Washington B Cárdenas; Gaya K Amarasinghe; Viktor E Volchkov; Christopher F Basler
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

9.  Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.

Authors:  Thomas W Geisbert; Joan B Geisbert; Anders Leung; Kathleen M Daddario-DiCaprio; Lisa E Hensley; Allen Grolla; Heinz Feldmann
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

10.  Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae.

Authors:  Jens H Kuhn; Yiming Bao; Sina Bavari; Stephan Becker; Steven Bradfute; J Rodney Brister; Alexander A Bukreyev; Yíngyún Caì; Kartik Chandran; Robert A Davey; Olga Dolnik; John M Dye; Sven Enterlein; Jean-Paul Gonzalez; Pierre Formenty; Alexander N Freiberg; Lisa E Hensley; Anna N Honko; Georgy M Ignatyev; Peter B Jahrling; Karl M Johnson; Hans-Dieter Klenk; Gary Kobinger; Matthew G Lackemeyer; Eric M Leroy; Mark S Lever; Loreen L Lofts; Elke Mühlberger; Sergey V Netesov; Gene G Olinger; Gustavo Palacios; Jean L Patterson; Janusz T Paweska; Louise Pitt; Sheli R Radoshitzky; Elena I Ryabchikova; Erica Ollmann Saphire; Aleksandr M Shestopalov; Sophie J Smither; Nancy J Sullivan; Robert Swanepoel; Ayato Takada; Jonathan S Towner; Guido van der Groen; Viktor E Volchkov; Victoria Wahl-Jensen; Travis K Warren; Kelly L Warfield; Manfred Weidmann; Stuart T Nichol
Journal:  Arch Virol       Date:  2013-01-29       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.